24 related articles for article (PubMed ID: 15249136)
1. Blocking Kallikrein 6 promotes developmental myelination.
Yoon H; Triplet EM; Simon WL; Choi CI; Kleppe LS; De Vita E; Miller AK; Scarisbrick IA
Glia; 2022 Mar; 70(3):430-450. PubMed ID: 34626143
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms.
Yoon H; Radulovic M; Scarisbrick IA
Biol Chem; 2018 Sep; 399(9):1041-1052. PubMed ID: 29604205
[TBL] [Abstract][Full Text] [Related]
3. Correlation between KLK6 expression and the clinicopathological features of glioma.
Lou J; Si H; Chen Y; Sun X; Zhang H; Niu A; Hu C
Contemp Oncol (Pozn); 2014; 18(4):246-51. PubMed ID: 25258582
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.
Yoon H; Radulovic M; Wu J; Blaber SI; Blaber M; Fehlings MG; Scarisbrick IA
J Neurochem; 2013 Oct; 127(2):283-98. PubMed ID: 23647384
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.
Scarisbrick IA; Radulovic M; Burda JE; Larson N; Blaber SI; Giannini C; Blaber M; Vandell AG
Biol Chem; 2012 Apr; 393(5):355-67. PubMed ID: 22505518
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.
Scarisbrick IA; Yoon H; Panos M; Larson N; Blaber SI; Blaber M; Rodriguez M
Brain Pathol; 2012 Sep; 22(5):709-22. PubMed ID: 22335454
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.
Vandell AG; Larson N; Laxmikanthan G; Panos M; Blaber SI; Blaber M; Scarisbrick IA
J Neurochem; 2008 Nov; 107(3):855-70. PubMed ID: 18778305
[TBL] [Abstract][Full Text] [Related]
8. Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration.
Scarisbrick IA; Linbo R; Vandell AG; Keegan M; Blaber SI; Blaber M; Sneve D; Lucchinetti CF; Rodriguez M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):739-45. PubMed ID: 18627300
[TBL] [Abstract][Full Text] [Related]
9. Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the rat.
Haddock G; Cross AK; Allan S; Sharrack B; Callaghan J; Bunning RA; Buttle DJ; Woodroofe MN
Biochem Soc Trans; 2007 Aug; 35(Pt 4):692-4. PubMed ID: 17635124
[TBL] [Abstract][Full Text] [Related]
10. Expression of myelencephalon-specific protease in transient middle cerebral artery occlusion model of rat brain.
Uchida A; Oka Y; Aoyama M; Suzuki S; Yokoi T; Katano H; Mase M; Tada T; Asai K; Yamada K
Brain Res Mol Brain Res; 2004 Jul; 126(2):129-36. PubMed ID: 15249136
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor necrosis factor alpha in nerve fibers and oligodendrocytes after transient focal ischemia in mice.
Ohtaki H; Yin L; Nakamachi T; Dohi K; Kudo Y; Makino R; Shioda S
Neurosci Lett; 2004 Sep; 368(2):162-6. PubMed ID: 15351441
[TBL] [Abstract][Full Text] [Related]
12. Expression of myelencephalon-specific protease after cryogenic lesioning of the rat parietal cortex.
Oka Y; Uchida A; Aoyama M; Fujita M; Hotta N; Tada T; Katano H; Mase M; Asai K; Yamada K
J Neurotrauma; 2005 Apr; 22(4):501-10. PubMed ID: 15853466
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats.
Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O
Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555
[TBL] [Abstract][Full Text] [Related]
14. The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers.
Li F; Hayashi T; Jin G; Deguchi K; Nagotani S; Nagano I; Shoji M; Chan PH; Abe K
Brain Res; 2005 Jun; 1048(1-2):59-68. PubMed ID: 15921666
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
